HomeCADL • NASDAQ
add
Candel Therapeutics Inc
Previous close
$4.84
Day range
$4.56 - $5.07
Year range
$0.77 - $14.30
Market cap
156.24M USD
Avg Volume
390.09K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.11M | -5.59% |
Net income | -10.65M | -26.21% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -8.51M | 1.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.56M | -61.48% |
Total assets | 21.52M | -57.02% |
Total liabilities | 36.77M | 36.00% |
Total equity | -15.26M | — |
Shares outstanding | 32.48M | — |
Price to book | -10.30 | — |
Return on assets | -91.21% | — |
Return on capital | -468.04% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -10.65M | -26.21% |
Cash from operations | -6.57M | 25.37% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 1.68M | — |
Net change in cash | -4.90M | 45.06% |
Free cash flow | -3.32M | 44.66% |
About
Founded
2003
Headquarters
Website
Employees
42
